VIBRIO CHOLERAE

 

VIBRIO CHOLERAE

 

DEFINITION:

A bacterial infection of the small intestine caused by Vibrio Cholerae resulting in a secretory diarrhea.

EPIDEMIOLOGY:

  • incidence: ?
  • risk factors:
    • age: ?
    • season: ?
    • route: direct: fecal-oral, (animals play no role) indirect: water, food (shellfish)
    • environ: epidemic: nosocomial
    • endemic: developing countries, panendemics
  • incubation period: 6 hours -> 2 days

PATHOGENESIS:

1. Background

  • Vibrio Cholerae is a gram negative rod
    • 70 serotypes known and while many cause acute diarrhea only the 01 serotype causes cholera
    • two biotypes of 01 serotype: classic and El Tor
    • after ingestion, the vibrios multiply in the lumen & adhere to the surface of the epithelial cells underneath the mucous layer where they release an enterotoxin which has two subunits:

1. Binding Subunit

  • attaches to a GM1 ganglioside receptor on the surface of the epithelial cells

2. Active Subunit

  • enters the cell & activates adenylate cyclase -> increases cAMP -> decreases the active absorption of sodium and water in villus cells and increases the active secretion of chloride by crypt cells -> net loss of water & electrolytes into the lumen
  • both human and nonhuman reservoirs exist and V. cholerae may be transmitted as a subclinical infection
  • the El Tor biotype may survive for prolonged periods in water

CLINICAL FEATURES:

1. Diarrhea

  • variable
  • mild - yellow stool
  • severe - cholora gravis
    • sudden onset of painless and profuse watery diarrhea
    • up to 200-350 cc/kg/day
    • stool passed frequently and effortlessly
    • rice-water appearance (clear fluid with flecks of mucous)
    • slight fish-like odour of stool
    • may continue for 7 days
    • early sign of recovery is reappearance of bile pigment in stool
    • associated symptoms:
      • periumbilical cramps (50%), nausea/vomiting, no tenesmus,
      • severe dehydration and hypotonia
      • fever > 38 C (25%)
      • cyanosis and painful muscle cramps
      • lethargy, slurred speech, coma
      • glucose malabsorption rare
      • mortality (< 1%)

2. Complications

  • tetany, coma, seizures
  • pulmonary edema
  • arrhythmias (due to low K+)
  • paralytic ileus (due to low K+)
  • acute renal failure (ATN), hypokalemic nephropathy
  • hypokalemia, hypoglycemia

INVESTIGATIONS:

1. Stool

  • cultures - on TCBS agar
  • diarrheal fluid - isotonic with elevated bicarbonate & K+

2. Biopsy

  • small bowel (jejunum)
    • intact epithelium with minimal cellular response
    • slight edema of lamina propria
    • moderate dilation of capillaries and lymphatics
    • empty goblet cells (of mucous)

3. Serum

  • metabolic acidosis with severe dehydration
  • low K+, low glucose
  • serology:
    • vibriocidal and agglutinating antibody titres peak (4x or greater rise) at 1-2 weeks after the onset of illness and return to baseline 8-12 weeks after onset (diagnostic)
    • antitoxin titres remain elevated for up to 12-18 months

MANAGEMENT:

1. Supportive

  • oral rehydration fluid (ORF) and isotonic IV rehydration
  • replace HCO3, K+, glucose

2. Medications

  • Tetracycline 50mg/kg/day po q6h for 2-3 days
    • shortens duration and volume of diarrhea by 50-70%
    • shortens duration of carriage of Vibrio
  • others: doxycycline, furazolidone. erythromycin, TMP-SMX, chloramphenicol

3. Prevention:

  • avoid contaminated food and water
  • breastfeeding provides vibriocidal antibodies - VC rare in breast-fed infants
  • high potency cholerae vaccines offer 50-80% protection for up to 6 months in endemic regions but does not protect against transmission
  • chemoprophylaxis - with tetrcycline or doxycycline for 2 days decreases infection rates in household contacts

 

 

 

Pediatric Database - VIBRIO CHOLERAE

Pediatric Organization - Pedbase [at] Gmail.com